<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://ipcloseup.com/2026/09/01/2025-2030-patent-cliff-will-impact-some-pharma-companies-more-than-others/</loc><news:news><news:publication><news:name></news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-01T15:03:15+00:00</news:publication_date><news:title>2025-2030 Patent &#8220;Cliff&#8221; will Impact Some Pharma Companies More Than Others</news:title><news:keywords>investors, pharmaceutical companies, shareholder value, R&amp;D, AI, clinical trials, FDA, Bristol Myers Squibb, drug discovery, patent cliff, cancer drugs, compounds, Merc, Novo Nordisk, human clinical trials, treatments, medical science</news:keywords></news:news><image:image><image:loc>https://ipcloseup.com/wp-content/uploads/2026/08/1786128034891.jpg?w=121</image:loc></image:image></url></urlset>
